A Comprehensive Review of Cannabis in Patients with Cancer: Availability in the USA, General Efficacy, and Safety

被引:0
作者
Grant Steele
Tom Arneson
Dylan Zylla
机构
[1] Frauenshuh Cancer Center,Park Nicollet Oncology Research, HealthPartners Institute
[2] Minnesota Department of Health,undefined
[3] Office of Medical Cannabis,undefined
[4] University of Minnesota,undefined
来源
Current Oncology Reports | 2019年 / 21卷
关键词
Cannabis; Marijuana; Cancer; Palliative care;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 157 条
[31]  
Rossetti S(1975)Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy N Engl J Med 293 795-492
[32]  
Sanchez R(1979)Delta 9-tetrahydrocannabinol (THC) as an antiemetic in patients treated with cancerchemotherapy; a double-blind cross-over trial against placebo Vet Hum Toxicol 21 338-5872
[33]  
Sun W(2012)Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting J Natl Compr Cancer Netw 10 487-602
[34]  
Wright S(2014)Cannabinoids as therapeutic agents in cancer: current status and future implications Oncotarget 5 5852-586
[35]  
Kornyeyeva E(1975)Antineoplastic activity of cannabinoids J Natl Cancer Inst 55 597-406
[36]  
Fallon MT(2015)Cannabis in cancer care Clin Pharmacol Ther 97 575-357
[37]  
Zutt M(2016)A user’s guide to cannabinoid therapies in oncology Curr Oncol 23 398-672
[38]  
Hänßle H(2009)The analgesic potential of cannabinoids J Opioid Manag 5 341-1673
[39]  
Emmert S(2018)Association between US State Medical Cannabis Laws and Opioid Prescribing in the Medicare Part D Population JAMA Intern Med 178 667-undefined
[40]  
Neumann C(2014)Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010 JAMA Intern Med 174 1668-undefined